Isolated right hepatic duct dilation – Type VI of Mirizzi syndrome?

Longchang Chen, Yan Sun, Quanda Liu · 2025

Read Isolated right hepatic duct dilation – Type VI of Mirizzi syndrome? by Longchang Chen, Yan Sun, Quanda Liu (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12719162.txt.

Introduction

Longchang Chen, Yan Sun, and Quanda Liu report an odd bile duct case in this 2025 paper. A woman in her thirties showed a widened right liver duct on scans, with no pain or jaundice. Blood tests showed raised liver enzymes, and images showed a mass in the duct that hinted at cancer.

Surgery told a fuller story. The gallbladder duct had merged with the liver duct high up, and a stone mass sat at the join. That setup mimics a known stone squeeze syndrome, but at a new site. The team cut out the harmed duct and gallbladder and rejoined the ducts. The case warns that stone disease can fake cancer on scans.

Catalog record

CREATORLongchang Chen, Yan Sun, Quanda Liu
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE7 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12719162

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Isolated right hepatic duct dilation – Type VI of Mirizzi syndrome?
Authors: Longchang Chen, Yan Sun, Quanda Liu
Published: 2025

Mirizzi syndrome (MS) is defined as biliary obstruction caused by extrinsic compression of the common hepatic duct (CHD) or common bile duct (CBD) from impacted gallstones in the cystic duct or Hartmann's pouch [1]. The compression may lead to different degrees of complex biliary obstruction, erosion, fibrosis, or fistula. According to the mostly accepted Csendes-Beltran's classification [1], there are 5 types of MS categorized by the extent of the CHD compression, erosion, with or without cholecystobiliary or cholecystoenteric fistula. The clinical manifestations of MS include fever, right upper abdominal pain, obstructive jaundice, and gallstone ileus. Different types of MS have relevant management algorithms [2].

A 37-year-old woman incidentally exhibited an isolated right hepatic duct (RHD) dilation and abnormalities in serum transaminases, and no remarkable clinical manifestations presented. Laboratory studies showed serum alanine aminotransferase 240 U/L, aspartate aminotransferase 158 U/L, alkaline phosphatase 579 U/L, γ-glutamyl transpeptidase 897 U/L, carbohydrate antigen 19–9 63.3 U/mL, and normal bilirubin. The abdominal magnetic resonance imaging (MRI) revealed RHD dilation and a mass in the dilated RHD, and the contrast-enhanced computed tomography (CT) demonstrated local wall thickness and enhancement of RHD (Figs. 1). A diagnosis of Bismuth Type IIIa hilar cholangiocarcinoma was suspected, whereas it should be differentiated from hepatolithiasis. An initial laparoscopic exploration found that the right hemiliver appeared ischemic, the gallbladder was atrophic, a solid mass (size of 2 cm × 2 cm) was arising from RHD with upstreaming dilation of the biliary trees (Fig. 2), and the common bile duct was normal. Therefore, due to a high suspicion of hilar cholangiocarcinoma and a dread of potential risk of tumor cell dissemination [3], a decision was made to convert to an open procedure. After meticulous anatomical dissection, it revealed that the cystic duct and Hartmann's pouch were merged with the RHD above the hepatic duct confluence, in which the solid mass was formed. The lesioned RHD and gallbladder were resected en bloc, followed by an end-to-side anastomosis of the proximal RHD to the left hepatic duct and insertion of a T-tube with limbs positioned into both the right and left hepatic ducts. Surgical exploration confirmed the RHD obstruction attributable to an impacted gallstone in the cystic duct, where a cholecystobiliary fistula was formed – a finding consistent with MS. The patient recovered uneventfully. The T-tube was removed 2 months later as the cholangiography was normal. During a 3-year follow-up, the patient maintained well, without occurrence biliary stricture or recurrent lithiasis on regular MRI examinations.Fig. 1T2-weighted MRI revealed isolated dilation of right hepatic duct (RHD) (asterisk), and a short-segment stricture of the right hepatic duct with a regular, round, and low-signal filling defect; contrast-enhanced CT demonstrated local wall irregular, eccentric thickness and enhancement of the RHD (arrow).Fig. 1Fig. 2The right hepatic duct (RHD) was obstructed by a mass (arrow), with a dilation of proximal biliary duct. The hanged duct was the distal RHD.Fig. 2

T2-weighted MRI revealed isolated dilation of right hepatic duct (RHD) (asterisk), and a short-segment stricture of the right hepatic duct with a regular, round, and low-signal filling defect; contrast-enhanced CT demonstrated local wall irregular, eccentric thickness and enhancement of the RHD (arrow).

The right hepatic duct (RHD) was obstructed by a mass (arrow), with a dilation of proximal biliary duct. The hanged duct was the distal RHD.

In this case, this manifestation was easily misdiagnosed as hilar cholangiocarcinoma, because a cholecystobiliary fistula occurring at RHD is an extremely rare condition, which is very difficult to be recognized. We propose adding a novel type VI to the Csendes-Beltran classification of Mirizzi syndrome, which constitutes a valuable extension to the current classification system (see Table 1). Importantly, the proposed type VI is diagnostically challenging and requires distinct therapeutic strategies.Table 1Modified Csendes-Beltran classification of Mirizzi Syndrome with Type VI [1].Table 1TypeDescriptionKey imaging featuresIExtrinsic compression of the common bile duct (CBD) by an impacted gallstoneSmooth tapered narrowing of CBD; no fistulaIICholecystobiliary fistula involving one-third of CBD circumferencePresence of biliary fistula, minimal wall defectIIICholecystobiliary fistula involving two-third of CBD circumferencePresence of biliary fistula, moderate wall defectIVCholecystobiliary fistula involving whole CBD circumferencePresence of biliary fistula, extensive wall disruptionVAny type plus cholecystoenteric fistulaPneumobilia, presence of bilioenteric fistulaVaWithout gallstone ileusWithout intestinal obstructionVbWith gallstone ileusPresence of small bowel obstruction, with impacted ectopic gallstoneVICholecystobiliary fistula involving isolated hepatic duct, commonly right hepatic duct (RHD)Abrupt cutoff or local stricture of RHD, filling defects, or presence of isolated RHD dilationNote: CBD = common bile duct; RHD = right hepatic duct.

Table 1Modified Csendes-Beltran classification of Mirizzi Syndrome with Type VI [1].Table 1TypeDescriptionKey imaging featuresIExtrinsic compression of the common bile duct (CBD) by an impacted gallstoneSmooth tapered narrowing of CBD; no fistulaIICholecystobiliary fistula involving one-third of CBD circumferencePresence of biliary fistula, minimal wall defectIIICholecystobiliary fistula involving two-third of CBD circumferencePresence of biliary fistula, moderate wall defectIVCholecystobiliary fistula involving whole CBD circumferencePresence of biliary fistula, extensive wall disruptionVAny type plus cholecystoenteric fistulaPneumobilia, presence of bilioenteric fistulaVaWithout gallstone ileusWithout intestinal obstructionVbWith gallstone ileusPresence of small bowel obstruction, with impacted ectopic gallstoneVICholecystobiliary fistula involving isolated hepatic duct, commonly right hepatic duct (RHD)Abrupt cutoff or local stricture of RHD, filling defects, or presence of isolated RHD dilationNote: CBD = common bile duct; RHD = right hepatic duct.

Modified Csendes-Beltran classification of Mirizzi Syndrome with Type VI [1].

Note: CBD = common bile duct; RHD = right hepatic duct.

CRediT authorship contribution statement

Longchang Chen: Writing – original draft. Yan Sun: Writing – review & editing. Quanda Liu: Conceptualization.

Ethical approval statement

Written informed consent was obtained from the patient for his anonymised information to be published in this article.

Funding

This work was supported by the High-Level Clinical Hospital and Research Center Capacity Building Project for Traditional Chinese Medicine [Grant No. HLCMHPP2023124].

Declaration of competing interest

Read the complete text